{"id":46353,"date":"2025-09-06T01:00:13","date_gmt":"2025-09-06T01:00:13","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/46353\/"},"modified":"2025-09-06T01:00:13","modified_gmt":"2025-09-06T01:00:13","slug":"cancer-drugs-among-33-life-saving-medicines-set-to-get-cheaper-after-gst-rate-cut-full-list","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/46353\/","title":{"rendered":"Cancer drugs among 33 life-saving medicines set to get cheaper after GST rate cut. Full list"},"content":{"rendered":"\n<p>Published on: Sept 05, 2025 02:46 pm IST <\/p>\n<p>    According to a release by the Press Information Bureau, the GST rate for &#8220;all other drugs and medicines&#8221; has been brought down from 12 percent to 5 percent.     <\/p>\n<p>The GST Council, chaired by union finance minister Nirmala Sitharaman, approved a sweeping rationalisation of GST rates to help ease the costs for the common man <a class=\"backlink\" target=\"_blank\" href=\"https:\/\/www.hindustantimes.com\/india-news\/everyday-essentials-to-luxury-travel-gst-cuts-shape-lives-in-varying-ways-101757011959837.html\" data-vars-page-type=\"story\" data-vars-link-type=\"Manual\" data-vars-anchor-text=\"in key areas like household items and critical healthcare.\" rel=\"nofollow noopener\">in key areas like household items and critical healthcare.<\/a><\/p>\n<p>     <img decoding=\"async\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/09\/g57696accacef1c987697f328a63f824b75460cf5f1bd7e3c1_1757062358407_1757062358597.jpg\" alt=\"The new GST rates will kick in on September 22, the first day of Navratri.(Representational)\" title=\"The new GST rates will kick in on September 22, the first day of Navratri.(Representational)\"\/>   The new GST rates will kick in on September 22, the first day of Navratri.(Representational)    <\/p>\n<p>In a major boost to public health, the Council recommended a reduction of GST from 12 percent to nil on 33 lifesaving drugs, and from 5 percent to nil on three critical drugs used for cancer, rare diseases and other severe chronic illnesses. According to a release by the Press Information Bureau, the GST rate for &#8220;all other drugs and medicines&#8221; has been brought down from 12 percent to 5 percent, while many medical devices and diagnostic kits will also fall under a lower tax bracket. The new rates will kick in on September 22, the first day of Navratri.<\/p>\n<p>      <strong>Complete List Of The 33 Lifesaving Drugs which will attract nil tax<\/strong><\/p>\n<p>The complete list of lifesaving drugs that the GST Council has slashed tax is as follows, according to the PIB release:<\/p>\n<ul>\n<li>Agalsidase Beta<\/li>\n<li>Imiglucerase<\/li>\n<li>Eptacog alfa (activated recombinant coagulation factor VIIa)<\/li>\n<li>Onasemnogene abeparvovec<\/li>\n<li>Asciminib<\/li>\n<li>Mepolizumab<\/li>\n<li>Pegylated Liposomal Irinotecan<\/li>\n<li>Daratumumab (including subcutaneous)<\/li>\n<li>Teclistamab<\/li>\n<li>Amivantamab<\/li>\n<li>Alectinib<\/li>\n<li>Risdiplam<\/li>\n<li>Obinutuzumab<\/li>\n<li>Polatuzumab vedotin<\/li>\n<li>Entrectinib<\/li>\n<li>Atezolizumab<\/li>\n<li>Spesolimab<\/li>\n<li>Velaglucerase Alpha<\/li>\n<li>Agalsidase Alfa<\/li>\n<li>Rurioctocog Alpha Pegol<\/li>\n<li>Idursulphatase<\/li>\n<li>Alglucosidase Alfa<\/li>\n<li>Laronidase<\/li>\n<li>Olipudase Alfa<\/li>\n<li>Tepotinib<\/li>\n<li>Avelumab<\/li>\n<li>Emicizumab<\/li>\n<li>Belumosudil<\/li>\n<li>Miglustat;<\/li>\n<li>Velmanase Alfa<\/li>\n<li>Alirocumab<\/li>\n<li>Evolocumab<\/li>\n<li>Cystamine Bitartrate<\/li>\n<li>CI-Inhibitor injection<\/li>\n<li>Inclisiran. (<a rel=\"nofollow noopener\" href=\"https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2163555\" target=\"_blank\" class=\"backlink\" data-vars-page-type=\"story\" data-vars-link-type=\"Manual\" data-vars-anchor-text=\"See PIB annexure\">See PIB annexure<\/a> for exact HSN mappings and the authoritative list.)<\/li>\n<\/ul>\n<p>       <img decoding=\"async\" class=\"lazy\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/09\/story_trending@2x.png\" alt=\"\" title=\"\"\/>            <a href=\"https:\/\/www.hindustantimes.com\" class=\"breadcrumbclick\" data-vars-event-label=\"Home_clicked\" data-vars-event-action=\"\/\" data-vars-event-cta=\"News\" rel=\"nofollow noopener\" target=\"_blank\">News<\/a> \/ <a href=\"https:\/\/www.hindustantimes.com\/india-news\" class=\"breadcrumbclick\" data-vars-event-label=\"India News_clicked\" data-vars-event-action=\"\/india-news\" data-vars-event-cta=\"India News\" rel=\"nofollow noopener\" target=\"_blank\">India News<\/a> \/ Cancer drugs among 33 life-saving medicines set to get cheaper after GST rate cut. Full list   <\/p>\n<p> See Less <\/p>\n","protected":false},"excerpt":{"rendered":"Published on: Sept 05, 2025 02:46 pm IST According to a release by the Press Information Bureau, the&hellip;\n","protected":false},"author":2,"featured_media":46354,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[18,29683,34542,135,19,17,34543,462,29680,2101],"class_list":{"0":"post-46353","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-eire","9":"tag-gst-council","10":"tag-gst-rates","11":"tag-health","12":"tag-ie","13":"tag-ireland","14":"tag-lifesaving-drugs","15":"tag-medication","16":"tag-nirmala-sitharaman","17":"tag-public-health"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/46353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=46353"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/46353\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/46354"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=46353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=46353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=46353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}